Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in ... Read More >>

Upcoming Events

There are currently no events scheduled.

Recent News

05/10/19

LabCorp Announces Availability of New QIAGEN therascreen FGFR mutation analysis companion diagnostic for Bladder Cancer

05/02/19

LabCorp to Webcast Its Annual Meeting of Shareholders

04/30/19

LabCorp Announces 2019 First Quarter Results and Increases 2019 Earnings Guidance

LH (Common)
ExchangeNYSE
Price$164.41
Change Stock is Down 0.58
Data as of 05/17/19 4:02 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet